Protective effects of All-trans-retinoic acid against cardiac arrhythmias induced by isoproterenol, lysophosphatidylcholine or ischemia and reperfusion

Journal of Cardiovascular Pharmacology
J X Kang, A Leaf

Abstract

Previous studies have shown that free polyunsaturated fatty acids (PUFA) reduce the excitability of cardiac myocytes and exert antiarrhythmic effects. Therefore, we hypothesized that retinoic acid (RA, vitamin A acid), which has structural characteristics similar to those of PUFA, may have similar antiarrhythmic effects. To test this hypothesis, we used an isolated, spontaneously beating, neonatal rat cardiac myocyte preparation to examine the effects of RA, added to the perfusion solution, on the cell contraction and arrhythmias induced by isoproterenol (ISO) or lysophosphatidylcholine (LPC). All-trans-RA (10-20 microM) induced a marked and reversible reduction in the contraction rate of the cell in 2-5 min without changing the amplitude of the contractions. Superfusion of the myocytes with either ISO (3 microM) or LPC (5 microM) induced sustained tachyarrhythmias characterized by spasmodic contractures and fibrillation. Addition of 15-20 microM all-trans-RA to the perfusion solution effectively prevented as well as terminated the arrhythmias induced by ISO and LPC. Furthermore, in a whole-animal model of arrhythmia in which the left anterior descending coronary artery (LAD) of the anesthetized rat was occluded for 15 min foll...Continue Reading

Citations

Sep 19, 2009·Cardiovascular Toxicology·Rajat SethiNaranjan S Dhalla
Nov 13, 2004·The Journal of Nutritional Biochemistry·K NageswariV P Menon
Nov 13, 2004·The Journal of Nutritional Biochemistry·W R LeifertE J McMurchie
Nov 1, 1997·Trends in Cardiovascular Medicine·S M Smith, E D Dickman
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J X Kang, A Leaf
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y F XiaoA Leaf
Mar 3, 2015·Journal of the Chinese Medical Association : JCMA·Chen-Hsiang Shih, Hung-Bo Wu
Mar 1, 2006·International Journal of Cardiology·Nipon ChattipakornSiriporn C Chattipakorn
Jun 17, 2018·The Journal of Pharmacology and Experimental Therapeutics·Alice MarinoRoberto Levi
Jan 5, 2000·The American Journal of Clinical Nutrition·J X Kang, A Leaf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.